Skip to main content
. 2011 Jul 5;105(4):565–574. doi: 10.1038/bjc.2011.249

Figure 6.

Figure 6

Kaplan–Meier survival analysis of melanoma patients, stratified according to cytoplasmic MSX2 expression. Recurrence-free survival of patients with (A) all melanoma subtypes and (B) SSM or nodular melanomas only. Overall survival of patients with (C) all melanoma subtypes and (D) SSM or nodular melanoma only.